Ipsen (OTC: IPSEY) muaj pom zoo kom tau Tsim tawm Albireo Pharma Inc. (Nasdaq: ALBO) ntawm $42.00 ib feem ntawm cov nyiaj ntsuab rau qhov pib kwv yees kwv yees kwv yees ntawm $ 952 lab ntxiv rau ib qho nqi sib tw (CVR) ib feem.
Txhua CVR yuav tso cai rau nws tus tswv kom ncua kev them nyiaj ntsuab ntawm $ 10.00 ib CVR them raws li FDA pom zoo ntawm Bylvay hauv Biliary Atresia qhia qhov tseeb los ntawm Lub Kaum Ob Hlis 31, 2027.
Kev nrhiav tau ntawm Albireo yuav muab kev muag khoom ntxiv tam sim thiab ntxiv dag zog rau Ipsen cov kab mob tsawg.
Albireo tau coj mus rau tag nrho Bylvay cov nyiaj tau los ntawm $ 24 lab rau 2022.
Qhov kev hloov pauv tau xav tias yuav ua rau muaj kev cuam tshuam rau Ipsen cov nyiaj tau los ua haujlwm tseem ceeb kom txog thaum kawg ntawm 2024.
Qhov kev pom zoo tau cia siab tias yuav kaw thaum kawg ntawm Q1 2023.
Cov tshuaj txhuas hauv Albireo cov raj xa dej yog Bylvay (odevixibat), tau pom zoo xyoo 2021 hauv Asmeskas rau pruritus hauv cov neeg mob peb lub hlis thiab laus dua nrog kev loj hlob hauv tsev neeg intrahepatic cholestasis (PFIC) thiab hauv EU rau PFIC hauv cov neeg mob hnub nyoog rau lub hlis lossis laus dua.
Raws li ib feem ntawm kev lag luam, Ipsen tseem yuav tau txais Albireo cov cuab yeej kho mob theem A3907, hauv kev txhim kho rau cov neeg laus mob cholestatic kab mob siab, uas tuaj yeem ntxiv rau Ipsen cov kev txhim kho uas twb muaj lawm.
Nqe Nqis: ALBO shares tau nce 92.59% ntawm $ 43.95 thaum lub sijhawm ua ntej kev lag luam ntawm daim tshev kawg hnub Monday.
Duab Ntawm Tuam Txhab
Saib ntxiv ntawm Benzinga
Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.
© 2023 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.
Tau qhov twg los: https://finance.yahoo.com/news/france-based-ipsen-acquires-albireo-112409310.html